| GALECTIN THERA. DL-,01 |
| USA |
| Gesundheit |
| US3632252025 / A1JV3R |
| PHPN (Frankfurt) / GALT (NASDAQ) |
| FRA:PHPN, ETR:PHPN, PHPN:GR, NASDAQ:GALT |
| - |
| http://www.galectintherap.. |
|
Galectin Therapeutics Inc. is a biotechnology company dedicated to developing therapies that target galectin proteins involved in the pathogenesis of various diseases. The company's primary focus is on producing innovative drug candidates aimed at tr..
>Volltext.. |
| 162.18 Mio. EUR |
| 269.21 Mio. EUR |
| - |
| -14.13 Mio. EUR |
| -22.88 Mio. EUR |
| -0.36 EUR |
| 118.31 Mio. EUR |
| 12.3 Mio. EUR |
| -17.48 Mio. EUR |
| 1.93 |
| - |
| 45.6% |
| - |
| - |
| - |
| GALECTIN |
| 23.06.26 |